T3D-959 pill for mild-to-moderate Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This trial tests an experimental pill, T3D-959, for people with mild-to-moderate Alzheimer's disease. The goal is to see if it can help slow memory and thinking decline. You would need to visit the clinic regularly for check-ups and memory tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 90 years old.
- You need a caregiver (like a family member or friend) who can help with study visits and report on your condition.
- You must have a confirmed diagnosis of Alzheimer's disease, including a positive blood test for a specific Alzheimer's protein.
- Your dementia should be in the mild or moderate stage (often checked with a memory test score between 14 and 26).
- You should be generally stable health-wise, with no major heart, liver, kidney, or psychiatric conditions that might interfere.
- You should be able to swallow pills and be willing to take study medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, VHB937, in people with early Alzheimer's (mild cognitive impairment or mild dementia). The goal is to see if it can slow down memory loss and thinking problems.
This study tests an experimental drug called RO7568282 for people in the early stages of Alzheimer's disease. The goal is to see if it is safe and whether it can slow down memory loss and thinking problems.
This trial tests a new drug, NBI-1117567, for people with mild to moderate Alzheimer's disease who are already taking a standard Alzheimer's medication. The goal is to see if the new drug can help improve symptoms.
This study tests a combination of brain stimulation (TMS) and cognitive training to improve memory and thinking in people with mild Alzheimer's. It may help if you are already on a stable dose of a donepezil-type medication and have a confirmed Alzheimer's diagnosis.
This trial tests whether a supplement called Neuroaid II can help people with mild to moderate Alzheimer's disease. It is a pill taken alongside your usual Alzheimer's treatments, and the study aims to see if it can slow down memory decline.
This study tests whether a daily pill (tadalafil, a type of medicine usually used for blood pressure or erectile dysfunction) can help people with early Alzheimer's or mild memory problems. It aims to see if this drug can improve memory and slow down the disease, with the help of regular checkups and brain scans.
Hear when a new Alzheimer’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.